A2 Biotherapeutics Inc.
Clinical trials sponsored by A2 Biotherapeutics Inc., explained in plain language.
-
Smart CAR t cells aim to outsmart solid tumors in new trial
Disease control Recruiting nowThis study tests a new type of CAR T cell therapy for adults with advanced solid tumors, including colorectal, pancreatic, lung, ovarian, and mesothelioma cancers. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells that have lost a specif…
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Could your cells hold the key to a new cancer therapy?
Knowledge-focused Recruiting nowThis study is gathering tumor tissue and blood cells from 200 adults with advanced solid tumors like colorectal, lung, or pancreatic cancer. The goal is to learn how often certain genetic changes occur and to store participants' own immune cells for possible future use in making …
Sponsor: A2 Biotherapeutics Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC